77.24
-0.30 (-0.39%)
-0.30 (-0.39%)
Upgrade to Real-Time
Afterhours (Closed)
Low
71.715
High
87.80
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.30 | -0.39% | 77.24 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 77.54 | 76.955 | 77.605 | 77.24 | 77.54 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 42,556 | 5,071,595 | $ 77.32 | $ 392,111,711 | - | 71.715 - 87.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:57:50 | 10 | $ 77.25 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 195.58B | 2.53B | 2.53B | $ 48.00B | $ 4.89B | 2.77 | 28.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.48 | 3.35% | 06/14/21 | 1.34M | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 77.81 | 78.3384 | 75.64 | 76.68 | 8,827,597 | -0.57 | -0.73% |
| 1 Month | 77.25 | 78.77 | 75.64 | 77.52 | 8,423,310 | -0.01 | -0.01% |
| 3 Months | 74.13 | 80.34 | 72.075 | 76.82 | 11,623,428 | 3.11 | 4.2% |
| 6 Months | 81.04 | 81.15 | 71.715 | 76.31 | 11,948,629 | -3.80 | -4.69% |
| 1 Year | 76.41 | 87.80 | 71.715 | 78.50 | 10,223,508 | 0.83 | 1.09% |
| 3 Years | 64.61 | 92.64 | 62.3805 | 78.78 | 10,306,199 | 12.63 | 19.55% |
| 5 Years | 58.70 | 92.64 | 52.83 | 71.89 | 9,972,600 | 18.54 | 31.58% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States. |
